Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Skin, Subcutaneous Tissue and BreastDRG 579-other-skin-subcutaneous-tissue-and-breast-procedures-with-mcc
    Ask Trek AI about this page

    Other Skin, Subcutaneous Tissue and Breast Procedures with MCC: Inpatient Reimbursement Overview

    DRG 579 addresses inpatient cases involving other skin, subcutaneous tissue, and breast procedures with a Major Complication or Comorbidity, encompassing complex excisions, reconstructions, and extensive debridements with significant comorbid medical conditions. It matters for inpatient reimbursement because the Major Complication or Comorbidity designation increases the Diagnosis-Related Group weight and prospective payment, reflecting higher expected resource use and cost for the hospital.

    Customize your policy alerts

    Sign up for drg 579 policy alerts

    Get alerted when payer policies referencing 579 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 579 Overview

    DRG 579 covers hospital admissions for other skin, subcutaneous tissue, and breast procedures when a Major Complication or Comorbidity is present. Typical cases include complex excisions, reconstructions, or extensive debridements of the skin and subcutaneous tissue, often with significant perioperative medical issues that increase resource use. This Diagnosis-Related Group affects payment because the presence of a Major Complication or Comorbidity raises the relative weight and prospective payment for the inpatient stay. It is relevant for surgical specialties such as general surgery, plastic surgery, and dermatologic surgery that manage complicated wound care and breast procedures.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute procedural efficacy and safety studies evaluating novel surgical or minimally invasive techniques for complex skin, subcutaneous tissue, and breast lesions with major complications: trials focus on immediate perioperative outcomes, complication rates, and resource utilization in hospitalized adults requiring debridement, excision, reconstruction, or drainage for infected, necrotic, or traumatically damaged tissue classified under this DRG. Patient population typically includes medically complex, often elderly or immunocompromised inpatients with major comorbidities (eg, sepsis, wound necrosis, large abscesses) where an MCC is present. These studies are relevant to providers and payers because they inform procedure selection, expected lengths of stay, and short-term costs tied to higher-acuity surgical management.
    • Comparative effectiveness research comparing different reconstructive strategies and perioperative care pathways for patients undergoing extensive soft-tissue or breast procedures with major complications: studies may compare local flap versus more complex reconstruction, staged procedures, or variation in wound management protocols (eg, negative-pressure wound therapy versus standard dressings) and examine outcomes such as reoperation, wound healing time, infection recurrence, and inpatient resource use. The enrolled population includes hospitalized patients with large defects or recurrent infections where choice of reconstruction materially affects recovery and complication rates. Findings guide clinicians and payers on which approaches reduce downstream utilization, readmissions, and total cost of care while maintaining acceptable clinical outcomes.
    • Post-discharge outcomes and care coordination studies assessing long-term functional recovery, readmission risk, and outpatient resource needs after hospitalization for skin/subcutaneous/breast procedures complicated by MCC: observational cohorts and care-pathway intervention studies evaluate home health needs, wound care adherence, outpatient surgical follow-up, and predictors of 30- and 90-day readmission or emergency visits. These studies target high-risk inpatients transitioning to outpatient care, aiming to identify modifiable factors that reduce costly readmissions and prolonged recovery. Results are important for payers and health systems designing discharge planning, bundled payments, and targeted post-acute services to improve outcomes and contain costs for this high-acuity DRG.

    Related Codes

    570-SKIN-DEBRIDEMENT-WITH-MCC

    Skin Debridement with Major Complication or Comorbidity: Inpatient Reimbursement Overview

    571-SKIN-DEBRIDEMENT-WITH-CC

    Skin Debridement with CC: Inpatient Reimbursement Overview

    572-SKIN-DEBRIDEMENT-WITHOUT-CC-MCC

    Skin Debridement without CC/MCC: Inpatient Reimbursement Overview

    573-SKIN-GRAFT-FOR-SKIN-ULCER-OR-CELLULITIS-WITH-MCC

    Skin Graft for Skin Ulcer or Cellulitis with MCC: Inpatient Reimbursement Overview

    574-SKIN-GRAFT-FOR-SKIN-ULCER-OR-CELLULITIS-WITH-CC

    Skin Graft for Skin Ulcer or Cellulitis with CC: Inpatient Reimbursement Overview

    575-SKIN-GRAFT-FOR-SKIN-ULCER-OR-CELLULITIS-WITHOUT-CC-MCC

    Skin Graft for Skin Ulcer or Cellulitis without CC/MCC: Inpatient Reimbursement Overview

    576-SKIN-GRAFT-EXCEPT-FOR-SKIN-ULCER-OR-CELLULITIS-WITH-MCC

    Skin Graft Except for Skin Ulcer or Cellulitis with MCC: Inpatient Reimbursement Overview

    577-SKIN-GRAFT-EXCEPT-FOR-SKIN-ULCER-OR-CELLULITIS-WITH-CC

    Skin Graft Except for Skin Ulcer or Cellulitis with CC: Inpatient Reimbursement Overview

    578-SKIN-GRAFT-EXCEPT-FOR-SKIN-ULCER-OR-CELLULITIS-WITHOUT-CC-MCC

    Skin Graft Except for Skin Ulcer or Cellulitis without CC/MCC: Inpatient Reimbursement Overview

    580-OTHER-SKIN-SUBCUTANEOUS-TISSUE-AND-BREAST-PROCEDURES-WITH-CC

    Other Skin, Subcutaneous Tissue and Breast Procedures with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 31

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.